I don't know. A lot of progress has been made already. The clothing division was sold off. PC has been recapitalized. The article that starteam posted says the company is looking to exit India (properties are listed for sale).
EMITF is my second largest position. I have gotten beaten up on it over the past eight months. Instead of trying to predict what the share price will do, I try to figure out what the separate assets are worth and buy value. It suits my personality, but it is not for everyone.
In many ways, the story is the same as it was a year ago. Plaza needs capital to complete its projects. It needs to sell its completed projects. The shares can then re-rate closer to book value. Insightec needs FDA approval on Neuro and greater acceptance on other procedures. For the most part, I consider Gamida-Cell to be sold and don't pay much attention to it. Hotels are fine, India needs to build or sell.
The Wall St. Journal did a follow-up story on uterine fibroids and the morcellators spreading cancer. This was one of the top rated comments by Morry Blumenfeld.
"There is a totally non-invasive way to remove fibroids by using focused ultrasound to ablate the tissue. This method, first cleared by the FDA in 2004, has had significant positive results, but is little known, for two reasons: reimbursement and turf. Focused ultrasound requires MRI to do real time planning, guidance, monitoring and control. MRI's are usually not "owned" by gynaecologists but by radiologists, creating a turf battle which is not helpful to patients. When the FDA cleared focused ultrasound for this application their FDA Talk Paper (Oct. 22, 2004) stated "FDA expedited review of the device because it offers significant advantages over existing treatments for uterine fibroids." It has been shown allow subsequent pregnancies (unlike hysterectomy) and even lets women return to their normal duties the same day. Despite this the insurance companies keep asking for more and more clinical studies before they provide reimbursement, although this is hopefully starting to change." - Morry Blumenfeld
I thought the conflict between gynos and radiologists was interesting and something I've never thought about
Bloomberg lists March 31 (consistent with last year). Plaza Centers is March 19th, with the annual report on April 30th per the PC website.
Yes, still a shareholder.
I don't think the real estate is a joke. I do think it is tough to value raw land and projects like Casa Radio and India.
Are you talking about the March 4th DealCurry article about the sale of the Pune-Koregaon mall? There have been several conflicting news articles on this sale. I was under the impression that the sale is still in the due diligence phase.
Just reading the article, it is somewhat disappointing that global financial firms are rushing into commercial real estate in India and EPI is leaving. It seems like the India division could have been massive, EPI was just too early.
It looks like amendments to the 5th Ave lease agreement.
I've seen a lot of promotion of the 40th season of SNL with special guest appearances and such. It should help buoy interest in the exhibition. I think it is New York centric and probably wouldn't travel well.
I just started following MERU. Why would Eric Singer resign from the board and then threaten/reserve the right to replace the board in the future if the company remains independent?
Doesn't the hiring of Deutsche Bank and a new slate of directors mean the company will have to be sold before the next shareholder meeting (May)? Or the current board will be thrown out?
I was trying to figure that out as well. Appalachian is a publicly traded brewery, but with $300K in sales last quarter, why would BREW even waste time on this. It seems like a start-up brewery looking to capitalize on the craft wave in order to sell stock (not beer). HOPS has a $30 million market cap.
When the debt was restructured there were a lot of shares issued (debt holders received 95% of the company). Then there was a 1 for 20 reverse split. There is now 27,572,425 shares outstanding and the company has a USD 47 million market cap. The data feeds to yahoo are not accurate, but some other websites have the correct information.